FDA takes first step in possible reversal of ban on some peptides The Washington Post In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BioCentury RFK Jr.'s peptide deregulation threatens the foundations of drug safety